A real-world study of the efficacy and safety of anti-programmed cell death-1 therapy combined with chemotherapy or targeted therapy in patients with advanced biliary tract cancer

BACKGROUND: Immune checkpoint inhibitors (ICIs) represent a breakthrough in cancer treatment. However, they have rarely been used to treat biliary tract cancer (BTC). In the current study, we aimed to evaluate and compare the efficacy and safety of anti-programmed cell death-1 (PD-1) therapy used al...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Gastrointest Oncol
Main Authors: Sun, Danyang, Ma, Junxun, Wang, Jinliang, Wang, Lijie, Zhang, Sujie, Chen, Guangying, Li, Xiaoyan, Cui, Pengfei, Zheng, Xuan, Hu, Yi
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7807271/
https://ncbi.nlm.nih.gov/pubmed/33457011
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo-20-562
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados